UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss

Nature metabolism, 2019-12, Vol.1 (12), p.1202-1208

2019

Volltextzugriff (PDF)

Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes

Nature communications, 2023-07, Vol.14 (1), p.4514-4514, Article 4514

2023

Volltextzugriff (PDF)

Pelvic Floor Muscle Training Versus Watchful Waiting and Pelvic Floor Disorders in Postpartum Women: A Systematic Review and Meta-analysis

Female pelvic medicine & reconstructive surgery, 2018-03, Vol.24 (2), p.142

2018

Volltextzugriff (PDF)

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

The Lancet (British edition), 2017-11, Vol.390 (10110), p.2347-2359

2017

Volltextzugriff (PDF)

Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin

The journal of clinical endocrinology and metabolism, 2020-08, Vol.105 (8), p.2532-2540

2020

Volltextzugriff (PDF)

Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial

The journal of clinical endocrinology and metabolism, 2017-05, Vol.102 (5), p.1596-1605

2017

Volltextzugriff (PDF)

Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial

Diabetes care, 2022-01, Vol.45 (1), p.178-185

2022

Volltextzugriff (PDF)

Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial

Diabetes care, 2018-12, Vol.41 (12), p.2471-2479

2018

Volltextzugriff (PDF)

Mindfulness for the Mental Health and Well-Being of Post-Secondary Students: A Systematic Review and Meta-Analysis

Mindfulness, 2019-03, Vol.10 (3), p.397-414

2019

Volltextzugriff (PDF)

Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes

Diabetes care, 2020-06, Vol.43 (6), p.1178-1184

2020

Volltextzugriff (PDF)

Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes (RESET‐IT Main): A 2‐year randomized controlled trial

Diabetes, obesity & metabolism, 2021-08, Vol.23 (8), p.1926-1935

2021

Volltextzugriff (PDF)

Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial

Diabetes, obesity & metabolism, 2023-11, Vol.25 (11), p.3347-3355

2023

Volltextzugriff (PDF)

Remission of Type 2 Diabetes

Canadian journal of diabetes, 2022-12, Vol.46 (8), p.753-761.e8

2022

Volltextzugriff (PDF)

Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based, Randomized, Controlled Trial

Canadian journal of diabetes, 2021-10, Vol.45 (7), p.594-600

2021

Volltextzugriff (PDF)

677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

1 - The Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based Randomized Controlled Trial

Canadian journal of diabetes, 2020-10, Vol.44 (7), p.S2-S2

2020

Volltextzugriff (PDF)

Dietary Patterns of Insulin Pump and Multiple Daily Injection Users During Type 1 Diabetes Pregnancy

Diabetes care, 2020-01, Vol.43 (1), p.e5-e7

2020

Volltextzugriff (PDF)

22 - Remission and Regression Following a Short-Term Intensive Metabolic Intervention With Insulin Glargine, Metformin and Dapagliflozin: The REMIT-DAPA Trial

Canadian journal of diabetes, 2019-10, Vol.43 (7), p.S9-S9

2019

Volltextzugriff (PDF)

A Case of Nephrogenic Diabetes Insipidus Associated with Anidulafungin Treatment

Canadian journal of diabetes, 2015-12, Vol.39 (6), p.530-530

2015

Volltextzugriff (PDF)

Remission of Type 2 Diabetes: Diabetes Canada Clinical Practice Guidelines Expert Working Group

Canadian journal of diabetes, 2022-12, Vol.46 (8), p.753-761.e8

2022

Volltextzugriff (PDF)

Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial

Canadian journal of diabetes, 2022-03, Vol.46 (2), p.165-170

2022

Volltextzugriff (PDF)

Continuous Glucose Monitoring Time-in-Range and HbA 1c Targets in Pregnant Women with Type 1 Diabetes

Diabetes technology & therapeutics, 2021-10, Vol.23 (10), p.710

2021

Volltextzugriff (PDF)

The Diabetes Health Coaching Randomized Controlled Trial: Rationale, Design and Baseline Characteristics of Adults Living With Type 2 Diabetes

Canadian journal of diabetes, 2019-10, Vol.43 (7), p.477-482

2019

Volltextzugriff (PDF)

CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol

BMC pregnancy and childbirth, 2016-07, Vol.16 (1), p.167-167, Article 167

2016

Volltextzugriff (PDF)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2015-09, Vol.386 (9999), p.1137-1146

2015

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(15)
Endocrinology & Metabolism
(14)
Insulin
(12)
Diabetes
(11)
Diabetes Mellitus
(11)
Female
(10)
Adult
(9)
Metformin
(7)
Glucose
(6)
Hypoglycemic Agents - Therapeutic Use
(6)
Pregnancy
(6)
Type 2 Diabetes
(6)
Blood Glucose
(5)
Blood Glucose - Analysis
(5)
Clinical Trials
(5)
Diabetes Mellitus, Type 2 - Therapy
(5)
Glycated Hemoglobin A - Analysis
(5)
Male
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss

Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes

Pelvic Floor Muscle Training Versus Watchful Waiting and Pelvic Floor Disorders in Postpartum Women: A Systematic Review and Meta-analysis

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin

Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial

Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial

Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial

Mindfulness for the Mental Health and Well-Being of Post-Secondary Students: A Systematic Review and Meta-Analysis

Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes

Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes (RESET‐IT Main): A 2‐year randomized controlled trial

Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial

Remission of Type 2 Diabetes

Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based, Randomized, Controlled Trial

677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

1 - The Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based Randomized Controlled Trial

Dietary Patterns of Insulin Pump and Multiple Daily Injection Users During Type 1 Diabetes Pregnancy

22 - Remission and Regression Following a Short-Term Intensive Metabolic Intervention With Insulin Glargine, Metformin and Dapagliflozin: The REMIT-DAPA Trial

A Case of Nephrogenic Diabetes Insipidus Associated with Anidulafungin Treatment

Remission of Type 2 Diabetes: Diabetes Canada Clinical Practice Guidelines Expert Working Group

Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial

Continuous Glucose Monitoring Time-in-Range and HbA 1c Targets in Pregnant Women with Type 1 Diabetes

The Diabetes Health Coaching Randomized Controlled Trial: Rationale, Design and Baseline Characteristics of Adults Living With Type 2 Diabetes

CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Suchergebnisse filtern